Explore more publications!

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on April 21, 2026

Africa International Defence Exhibition 2026 to Connect Global Defence Industry with African Buyers Across the Continent
Quantum General Intelligence Inc. Unveils Q-Prime, the World's First Commercial Quantum Embedding Model on HuggingFace
More South Africans Are Selling Damaged Cars as Repair Costs Continue to Climb
NoOnes Confirms Stablecoin Explosion in Africa – Now 60% of All Trades
Chapel Hill Denham’s Philip Southwell Expected to Join Global Trading Championship, Firm Says
Tensões no Médio Oriente trazem desafios para o Agronegócio
CortexForge Marks Year One with Integration as the First Proof
FMUSER Releases Multi-Language Video Guide for Setting Up Hotel IPTV Systems
Zoomex startet ZoomexStocks: Handel mit globalen Aktien in USDT + zeitlich begrenzte Gebühren-Rückerstattungsaktion
TradeView Unveils Perps DEX Platform as Ongoing Presale Hits New Milestone
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
TradeView Releases New Guide on Platform Utility and Market Position
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation  Evolution

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions